Rise Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-30
| Closed | -$469 | – | 1183 |
|
|
2024
Q3 | $469 | Hold |
30
| – | – | ﹤0.01% | 1195 |
|
|
2024
Q2 | $514 | Hold |
30
| – | – | ﹤0.01% | 1192 |
|
|
2024
Q1 | $469 | Hold |
30
| – | – | ﹤0.01% | 1217 |
|
|
2023
Q4 | $448 | Hold |
30
| – | – | ﹤0.01% | 569 |
|
|
2023
Q3 | $485 | Sell |
30
-25
| -45% | -$404 | ﹤0.01% | 582 |
|
|
2023
Q2 | $2.28K | Hold |
55
| – | – | ﹤0.01% | 502 |
|
|
2023
Q1 | $3.31K | Hold |
55
| – | – | ﹤0.01% | 509 |
|
|
2022
Q4 | $4.03K | Hold |
55
| – | – | ﹤0.01% | 474 |
|
|
2022
Q3 | $4K | Sell |
55
-50
| -48% | -$3.64K | ﹤0.01% | 471 |
|
|
2022
Q2 | $7K | Hold |
105
| – | – | 0.01% | 401 |
|
|
2022
Q1 | $9K | Buy |
105
+30
| +40% | +$2.57K | 0.01% | 348 |
|
|
2021
Q4 | $5.63K | Buy |
+75
| New | +$5.63K | 0.01% | 394 |
|